一种可注射的水凝,具有逐步释放的药物,用于瘤的化学光热疗法
Ruixuan Chen1, Xuanying Liang1, Genquan Wu1
1Department of Biomedical Engineering, College of Engineering, Shantou University, Shantou 515063, China.
Langmuir : the ACS journal of surfaces and colloids
|January 12, 2026
概括
这项研究引入了一种可注射的水凝,用于持续的双重作用的癌症治疗. 这种新的水凝将化疗与光热疗法结合在一起,提供增强的瘤细胞杀伤和抑制生长.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 传统化疗面临诸如不可持续的药物释放,耐药性和全身毒性等挑战.
- 需要先进的药物输送系统来提高治疗效率并减少副作用.
研究的目的:
- 开发一种新型的可注射水凝,用于配送线粒 (MTO) 和黑量子点 (BP),用于化疗和光热疗法.
- 为了实现逐步释放药物,增强瘤切除和长期增长抑制.
主要方法:
- 使用奇托和β-甘油酸盐制造可注射水凝.
- 在水凝中加载米托克桑 (MTO) 和MTO加载的PEGylated黑量子点 (BP-PEG-MTO).
- 评估水凝结构,药物加载和逐步释放动力学.
- 在体外和体内评估化学光热疗法的疗效.
主要成果:
- 水凝呈现出3D多孔结构,增强了药物加载,并允许分阶段释放MTO.
- 结合化学疗法和光热疗法 (PTT) 导致瘤的迅速切除和持续的MTO释放.
- 在体外和体内观察到对瘤细胞的细胞毒性作用显著增强和瘤生长的抑制.
结论:
- 开发的可注射水凝系统有效地结合化疗和PTT用于局部癌症治疗.
- 逐步释放药物和双疗法方法显示出改善癌症治疗结果的希望.
- 这一策略为先进的瘤治疗提供了可行的途径,系统毒性降低.
相关概念视频
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177


